Schedule-dependent topoisomerase II-inhibiting drugs

This publication has 28 references indexed in Scilit:

• Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study.
  Journal of Clinical Oncology, 1993
• Prospective study of etoposide scheduling in combination chemotherapy for limited disease small cell lung carcinoma
  European Journal of Cancer and Clinical Oncology, 1991
• Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group Study
  JNCI Journal of the National Cancer Institute, 1991
• Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide
  Nucleic Acids Research, 1991
• A phase II study of oral etoposide in elderly patients with small cell lung cancer.
  Thorax, 1989
• In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy
  Cancer Chemotherapy and Pharmacology, 1987
• Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
  Annals of Internal Medicine, 1982
• A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry
  Cancer Chemotherapy and Pharmacology, 1981
• The Epipodophyllotoxin Derivatives VM-26 and VP-16-213, 1976–1979, a Review
  Published by Springer Nature ,1980
• SCHEDULE DEPENDENCY OF THE ANTILEUKEMIC ACTIVITY OF THE PODOPHYLLOTOXIN‐DERIVATIVE VP 16–213 (NSC‐141540) IN L1210 LEUKEMIA
  Acta Pathologica Microbiologica Scandinavica Section A Pathology, 1973